Twynsta (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Twynsta drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | telmisartan/amlodipine |
| SUBSTANCE NAME: | TELMISARTAN; AMLODIPINE BESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, MULTILAYER |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-11-02 |
| END MARKETING DATE: | 0000-00-00 |
Twynsta HUMAN PRESCRIPTION DRUG Details:
| Item Description | Twynsta from Boehringer Ingelheim Pharmaceuticals, Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40; 5(mg/1; mg/1) |
| START MARKETING DATE: | 2009-11-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0124_7c71ba01-79b3-2b3d-66e7-d12219ecc617 |
| PRODUCT NDC: | 0597-0124 |
| APPLICATION NUMBER: | NDA022401 |
Other TELMISARTAN; AMLODIPINE BESYLATE Pharmaceutical Manufacturers / Labelers:
